Is the sanctuary where Helicobacter pylori avoids antibacterial treatment intracellular? - PubMed (original) (raw)
Is the sanctuary where Helicobacter pylori avoids antibacterial treatment intracellular?
L Engstrand et al. Am J Clin Pathol. 1997 Nov.
Abstract
The sanctuary site where Helicobacter pylori evades antimicrobial therapy is unknown, but considerable data exist about an intracellular location for H pylori. Ten H pylori-infected volunteers received standard triple antimicrobial therapy for 2 weeks. Gastric mucosal biopsy specimens were obtained with jumbo forceps on therapy days 0, 3, 14, and 42. Hematoxylin-eosin staining was used for classification of gastritis and the Genta stain for the visualization of H pylori. Immunohistochemical staining was used to detect HLA-DR antigens, human heat shock protein (HSP60), and the bacterial HSP60 antigen. Bacterial HSP60 was expressed on the mucosal surface and within epithelial cells. No such expression of human HSP60 was found, which supports a bacterial origin for the intracellular HSP60. Coexpression of bacterial HSP60 and HLA-DR was always observed, indicating an ongoing local immune response. Infection was cleared on day 14, but when examined 4 weeks after completion of therapy, Genta staining indicated that only five volunteers remained free of H pylori. However, results of immunohistochemical staining were negative at this time for only two volunteers. Disappearance of intracellular expression of bacterial HSP60 remained after therapy and correlated with the intensity of chronic inflammatory cell infiltration. These data are consistent with the intracellular localization of H pylori having a role in inflammation and as a protective strategy against extracellular antibacterial activity.
Similar articles
- Anti-inflammatory and tissue-protectant drug effects: results from a randomized placebo-controlled trial of gastritis patients at high risk for gastric cancer.
Fischbach LA, Correa P, Ramirez H, Realpe JL, Collazos T, Ruiz B, Bravo LE, Bravo JC, Casabon AL, Schmidt BA. Fischbach LA, et al. Aliment Pharmacol Ther. 2001 Jun;15(6):831-41. doi: 10.1046/j.1365-2036.2001.00998.x. Aliment Pharmacol Ther. 2001. PMID: 11380321 Clinical Trial. - A virulence factor of Helicobacter pylori: role of heat shock protein in mucosal inflammation after H. pylori infection.
Kamiya S, Yamaguchi H, Osaki T, Taguchi H. Kamiya S, et al. J Clin Gastroenterol. 1998;27 Suppl 1:S35-9. doi: 10.1097/00004836-199800001-00007. J Clin Gastroenterol. 1998. PMID: 9872496 - Helicobacter pylori.
Seifrit B. Seifrit B. AORN J. 1997 Mar;65(3):614-6, 619-20. doi: 10.1016/s0001-2092(06)63082-2. AORN J. 1997. PMID: 9061156 Review. No abstract available. - [Management of the peptic ulcer patient in the Helicobacter pylori age].
Marshall BJ. Marshall BJ. Enferm Infecc Microbiol Clin. 1994 May;12 Suppl 1:36-40. Enferm Infecc Microbiol Clin. 1994. PMID: 7914434 Review. Spanish. No abstract available.
Cited by
- How Long Will It Take to Launch an Effective Helicobacter pylori Vaccine for Humans?
Li S, Zhao W, Xia L, Kong L, Yang L. Li S, et al. Infect Drug Resist. 2023 Jun 15;16:3787-3805. doi: 10.2147/IDR.S412361. eCollection 2023. Infect Drug Resist. 2023. PMID: 37342435 Free PMC article. Review. - Enhanced enzymatic production of cholesteryl 6'-acylglucoside impairs lysosomal degradation for the intracellular survival of Helicobacter pylori.
Muthusamy S, Jan HM, Hsieh MY, Mondal S, Liu WC, Ko YA, Yang WY, Mong KT, Chen GC, Lin CH. Muthusamy S, et al. J Biomed Sci. 2021 Oct 27;28(1):72. doi: 10.1186/s12929-021-00768-w. J Biomed Sci. 2021. PMID: 34706729 Free PMC article. - Isothiocyanates: An Overview of Their Antimicrobial Activity against Human Infections.
Romeo L, Iori R, Rollin P, Bramanti P, Mazzon E. Romeo L, et al. Molecules. 2018 Mar 9;23(3):624. doi: 10.3390/molecules23030624. Molecules. 2018. PMID: 29522501 Free PMC article. Review. - Mechanism of H. pylori intracellular entry: an in vitro study.
Liu H, Semino-Mora C, Dubois A. Liu H, et al. Front Cell Infect Microbiol. 2012 Mar 1;2:13. doi: 10.3389/fcimb.2012.00013. eCollection 2012. Front Cell Infect Microbiol. 2012. PMID: 22919605 Free PMC article. - Helicobacter pylori is invasive and it may be a facultative intracellular organism.
Dubois A, Borén T. Dubois A, et al. Cell Microbiol. 2007 May;9(5):1108-16. doi: 10.1111/j.1462-5822.2007.00921.x. Epub 2007 Mar 26. Cell Microbiol. 2007. PMID: 17388791 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous